[Source: Kunming Information Port_Original]
Statement: The copyright of this article belongs to the original author. If the source is wrong or infringes your legal rights, you can contact us by email, we will will be processed in a timely manner. Email address: [email protected]
In recent years, with the popularization of electronic products and the impact of the environment, the incidence of dry eye continues to increase. Data show that in ophthalmology clinics, dry eye patients account for up to 30%, and the diagnosis and treatment of dry eye disease has always been a difficult problem for ophthalmologists to overcome. On the afternoon of May 28th, Kunming Aiwei Eye Hospital held a press conference on the new technology of LipiFlow thermal pulse in the dry eye treatment “moisturizing” series, bringing high-quality eye health services to dry eye patients in the province.
Meibomian gland dysfunction is one of the main causes of dry eye p>
The causes of dry eye are complex. In addition to long-term use of electronic products, mental and psychological factors, environmental pollution, and systemic diseases may all cause dry eye. In the diagnosis of dry eye, it is very important to accurately distinguish the type of dry eye.
Zhang Yuying, director of ocular surface and corneal disease specialist of Kunming Aiwei Eye Hospital, introduced that dry eye can be roughly divided into tear deficiency type There are three types of evaporative type and mixed type: lacrimal deficiency type, which is characterized by insufficient secretion of tears from the lacrimal gland, and it is difficult to maintain the surface of the eyeball moist, that is, “water shortage”. The excessive evaporation type, caused by Meibomian gland dysfunction (MGD), is manifested as insufficient oil in the tears, which evaporates too quickly, that is, “oil deficiency”. Among them, evaporative (oil-deficient) dry eye caused by Meibomian gland dysfunction is the most common.
“The incidence of Meibomian gland dysfunction is very high in China. About 70-80% of dry eye patients in outpatient clinics are associated with Meibomian gland dysfunction. MGD and dry eye are mutually causal and affect the therapeutic effect. MGD has not been properly treated, and dry eye cannot be effectively treated. The LipiFlow Meibomian glandular heat pulsation therapy device introduced in our hospital this time can well unblock the meibomian glands and treat dry eye from the cause.” Zhang Yuying said.
The treatment principle of LipiFlow is to heat the inside of the eyelid through a constant temperature of 42.5°C, the heat reaches the meibomian glands, melts the blocked meibum, and the heater is designed with an insulating layer and an arched structure to ensure safety. At the same time, the outer eyelid is massaged with pulsating pressure in different modes of the eye cup airbag, with a comfortable force, the melted meibum is discharged, and the meibomian glands are unclogged.
LipiFlow takes 12 minutes for a single treatment, which is convenient, comfortable and safe. Most patients will not feel obvious pain during the whole process, and the effect of a single treatment can be maintained for 6 months. At the same time, LipiFlow has also passed the triple certification of FDA, CE and CFDA.
At the event site, under the leadership of the medical staff of Aiwei Eye Hospital, everyone also carried out self-assessment and self-test of dry eye. Blink exercise teaching. Facing the questions raised by patients and friends, Zhang Yuying also eliminated many doubts and confusions of dry eye patients present through professional and rigorous answers in simple language.
LipiFlow in the treatment of Meibomian gland dysfunction: 12 minutes, from block to pass
In addition, Xiao Yungao, President of Yunnan Aiwei Eye Medical Group mentioned , China has entered an age of aging, the incidence of cataracts in people aged 60 to 89 is about 80%, as a manifestation of physiological decline, if life is long enough, everyone can not avoid cataracts. Research shows that 52% of cataract patients suffer from Meibomian gland dysfunction. It is recommended that cataract patients should diagnose and treat Meibomian gland dysfunction before surgery to improve visual effects and achieve good postoperative visual quality and comfort.
“I am a dry eye patient myself, and I use my eyes very hard when I see a doctor and perform surgery. I often feel dry eyes, foreign body sensation, etc., which is very inconvenient.” Xiao Yungao introduced that traditional dry eye treatment requires medical staff to manually squeeze and dredge the meibomian glands, which will cause some discomfort. The whole treatment process of LipiFlow is very comfortable, no pain, 12 minutes of non-invasive physical therapy, through the simultaneous hot compress and massage on the inside and outside of the eyelid, it is very good to relieve the blockage of the meibomian glands.
Similar to glaucoma, retinal degeneration and other diseases, dry eye is a chronic ophthalmic disease. “Although the incidence rate is high and the population is wide, many people do not know that ‘dry eye’ is a disease and have no awareness of seeking medical treatment.” Zhang Yuying said that due to lack of awareness, many patients caused severe dry eye due to delayed treatment, and severe dry eye caused by Dryness causes repeated inflammation of the eye, destruction of the cornea, gradual loss of transparency, and ultimately possible blindness. Therefore, dry eye must be detected early, intervened early, and treated early.
In order to further improve the comprehensive diagnosis of dry eye and meet the individual needs of patients, Kunming Aiwei Eye Hospital took the lead in upgrading the dry eye diagnosis and treatment clinic, and established a dry eye chronic disease prevention and control system. Outpatient clinics carry out mid-term personalized and standardized diagnosis and treatment, accurate diagnosis and personalized treatment for patients; long-term follow-up of dry eye physiotherapists and regular science popularization to strengthen patients’ continuous treatment and home care habits. The introduction of LipiFlow new technology for pulsatile treatment of meibomian glandular fever marks a new level of dry eye diagnosis and treatment in Kunming Aivi Eye Hospital, and also brings good news to dry eye patients in Yunnan and surrounding areas. (Kunming Information Port reporter Cao Yue)